Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published June 1, 2002 | public
Journal Article

Elements of Transcription Factor Network Design for T-Lineage Specification

Abstract

The complex spectrum of cell types produced in mammalian hematopoiesis can be understood as the output of highly combinatorial transcription factor action. The generation of multiple diverse combinations of transcription factors from the common starting state of the hematopoietic stem cell must be explained through the cross-regulatory interactions of these transcription factors at several levels. Here, the operation of such a network is addressed through a focus on murine T cell development, where we have recently established regulatory linkages between GATA-3 and PU.1 and multiple other factors essential to this differentiation pathway. The action of both essential/rate-limiting factors and factors with effects that shift qualitatively with dose and time of action can be traced through the regulatory interaction network. Hypothetical models are proposed to indicate the network nodes that are differentially activated in normal T cell lineage progression and in cells diverted to other potential fates.

Additional Information

© 2002 Elsevier Science. Received for publication January 24, 2002; Revised March 25, 2002; Accepted March 25, 2002. We thank Drs. Meinrad Busslinger (IMP, University of Vienna), Cornelis Murre (University of California, San Diego), Harinder Singh (University of Chicago), and Irving Weissman (Stanford University) for stimulating and challenging discussions; our colleagues Eric Davidson and Jonathan Rast for valuable criticism and insightful advice throughout many stages of this work; and other members of the Rothenberg group for their experimental results, interpretations, and collegial generosity that have made this analysis possible. Work from the authors' lab described here was supported by grants from the National Institutes of Health (CA90233), the National Science Foundation (MCB-9983129), and initial consortium funding from the Stowers Institute for Medical Research.

Additional details

Created:
August 21, 2023
Modified:
October 24, 2023